Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SelectImmune Pharma Interim report Q1 2021/2022

Significant events On August 13th it was announced that SelectImmune Pharma is extending its presence on the international pharmaceutical arena, where research & development as well as clinical study results and strategic partnerships are typically reported in English. The company Board of Directors therefore decided to change the company language to English from 2021/2022 and onwards. The web site will feature parallel documents in English and Swedish, including annual reports, interim reports and press releases. On August 13th, Selectimmune Pharma announced a continued expansion of

G5 Entertainment releases new match-3 puzzle game Jewels of Orient in Canada

G5 Entertainment announces the release of its new free-to-play match-3 puzzle game, Jewels of Orient, currently only available in the Google Play Store and limited to Canada. The gradual rollout across all other countries and platforms to follow soon. With the company focused on new generation games, Jewels of Orient is a new addition to the Jewels family of games. In this match-3 puzzle game, players journey into a captivating adventure full of genies and gems as they quest to renovate and rebuild the once thriving empire. While players enjoy casual and relaxing gameplay, they can be

Aker Solutions to Provide Subsea Production System for Mero 4 Project in Brazil

November 18, 2021 – Aker Solutions has been awarded a substantial[1] contract by Petrobras to provide a subsea production system and related services for the Mero 4 project offshore Brazil. This is the fourth consecutive production system for the Mero field development, one of the largest oil discoveries in Brazil's pre-salt area.The company will deliver a subsea production system consisting of up to 13 vertical subsea trees designed for Brazil's pre-salt, including subsea distribution units, subsea control modules and master control station for control systems and topside, and related tie-

North American Tier 1 Operator and InCoax have successfully completed field trials

In accordance with the extended project agreement, the InCoax MoCA AccessTM technology for MultiGigabit broadband fiber access extension over coax, has successfully passed the field trials set up by the Tier 1 Operator. In the next step awaits further productization and commercialization of the solution which will commence in Q1, 2022.After a successful initial evaluation of InCoax MoCA Access 2.5 platform, InCoax entered an extended project agreement with the North American Tier 1 operator, which was communicated in October 2020. InCoax solution has now successfully passed the field trials

RESQUNIT AB receives conditional approval for listing of its shares on Nasdaq First North Growth Market in Stockholm and publishes a Company Description

Resqunit AB (publ) ("Resqunit" or "the Company") has applied for and received a conditional approval for admission to trading of its shares on Nasdaq First North Growth Market in Stockholm. In connection with the conditional approval, the Company hereby publishes a Company Description which is available on the Company's website www.resqunit.com. The approval is conditional on that a substantially unchanged Company Description is published, and that the Company's website fulfills the requirements as set in the Nasdaq First North Rulebook. Resqunit has in connection with the application to

BioStock: Pila Pharma CEO increases holding

When Malmö-based Pila Pharma started trading on Nasdaq First North Growth Market barely six months ago, founder and CEO Dorte X. Gram first entered the world of the stock market. Now, a few months later, she has increased her holding in the company.Read the full article at biostock.se:https://www.biostock.se/en/2021/11/pila-pharma-ceo-increases-holding/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 17th November 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,408,061 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Elicera Therapeutics AB (publ) Interim Report 1 January – 30 September 2021

Third quarter (July–September 2021) · Operating loss totaled SEK -6,753,799 (-216,550). · Loss for the period totaled SEK -6,753,799 (-211,132). · Cash flow from operating activities totaled SEK -13,418,888 (-104,589). · Earnings per share before dilution totaled SEK -0.34 (-0.02). Earnings per share after dilution amounted to SEK -0.34 (-0.02). Period (January–September 2021) · Operating loss totaled SEK -10,977,101 (-232,020). · Loss for the period totaled SEK -10,978,176 (-226,601). · Cash flow from operating activities totaled SEK -13,413,256 (-122,627). ·

Traditional foods hold top spot in Christmas buffet, though vegan herring has pushed out smoked mackerel

Modern vegetarian and vegan dishes have gained ground in the Christmas buffets on board Viking Line’s vessels, but traditional specialities have maintained their popularity year after year. This Christmas we are also offering individual portions in small wooden boats. “Along with using local ingredients, reducing food waste is an important part of our corporate responsibility,” says Viking Line’s restaurant manager, Janne Lindholm.The stars in Viking Line’s Christmas buffet are ham, casseroles and various fish dishes as starters. Alongside the traditional Christmas dishes, new vegetarian

EXTENDAM, CEDRE and CATELLA HOSPITALITY EUROPE acquire the iconic Hotel La Pérouse in Nice

A joint-venture led by Catella Hospitality Europe (CHE), Extendam and Cèdre has acquired the Hotel La Pérouse, a legendary boutique-hotel in Nice overlooking the famous “Baie des Anges”. This new acquisition is motivated by the unique features of the hotel as well as the demonstrated dynamism of Nice to be further consolidated with its recent UNESCO heritage site award.Nestled on the “Colline du Château”, at immediate vicinity from the old town of Nice, the Hotel La Pérouse offers a high-end experience to guests thanks to its exclusive environment and tailored services. Located on the

Wärtsilä contracted to supply three flexible thermal balancing power plants totalling 150 MW to Brazil

Wärtsilä Corporation, Press release, 18 November 2021 at 9:30 AM EETThe technology group Wärtsilä will supply three gas engine power plants with a combined output of 150 MW to Brazil. The contract award came as a result of a Reserve Capacity Auction organised by the Brazilian Ministry of Mines and Energy in October. The plants will be delivered on a fast-track basis and are scheduled to be operational in Q2, 2022. The orders were placed by companies held by funds managed by BTG Pactual Asset Management, and they are included in Wärtsilä’s order intake in Q4, 2021. The electricity

Interim report January-September 2021

We are making investments to meet a strong market growthThe third quarter demonstrates our capacity to deliver during a period of worldwide purchasing chain disruptions. At the same time, the market is maturing very rapidly towards the transition to a fossil-free future. Order intake increased during the quarter, to MSEK 11.8 (7.8), mostly attributable to follow-up orders from existing customers. The total order intake during the period January-September amounted to MSEK 126.9, which is a level significantly above the corresponding period in the previous year. Operating income for the

Epiroc’s ambitious climate targets validated as science based

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has received validation by the Science Based Targets initiative (SBTi) for the company’s ambitious targets to reduce CO\2\ emissions.In 2020, Epiroc launched ambitious sustainability goals that include halving its CO\2\ emissions by 2030. The SBTi has now validated Epiroc’s climate targets as being in line with keeping global warming at a maximum 1.5° C, consistent with the latest climate science and the goal of the Paris Climate Agreement.  “Climate change is

Notice of Extraordinary General Meeting of Inzile AB (publ)

The shareholders of Inzile AB (publ), 556907-0070, (the "Company") are hereby given notice to attend the Extraordinary General Meeting on 17 December, 2021. Due to the ongoing pandemic, the Board of Directors has decided that the Extraordinary General Meeting shall be conducted without the physical presence of shareholders, proxies and third parties, and that the exercise of voting rights may only take place by post prior to the meeting. Information on the Extraordinary General Meeting’s resolutions will be published as soon as the outcome of the postal vote is finally compiled on 17

Veoneer sets ambitious climate targets for a sustainable future

Stockholm, Sweden, November 18, 2021: Besides its overall goal to support halving the number of global deaths and injuries from road traffic accidents, the automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), announces ambitious carbon emission targets for a more sustainable future.Veoneer’s portfolio of technologies supports the Sustainable Development Goal #3 — halving the number of global deaths and injuries from road traffic accidents. Traffic safety is, together with the climate challenge, two of the global challenges where the automotive industry has a

Interim Report Scandinavian Enviro Systems AB (publ) January – September 2021

Eventful quarter strengthens our position going forward.N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail. Q3 2021 · Net revenues for the period were MSEK 1.4 (0.2) · Earnings after tax for the period were MSEK -11.6 (-12.7) · Earnings per share for the period (before dilution) was SEK -0.02 (-0.02) · Cash flow for the period after investments was MSEK -14.1 (-10.9) · Michelin has retained its ownership to 20% of the shares in Enviro after

Scandion Oncology A/S announces its results for the third quarter of 2021

Scandion Oncology today announces its third quarter report for 2021. The following is taken from the report. Bo Rode Hansen, President and CEO comments “During the third quarter, Scandion Oncology has continued the transformation towards the Cancer Drug Resistance company according to the company’s strategy. We completed the first Capital Markets Day where we conveyed the strategy for the registrational path to market of our clinical programs.” Key figures & highlights TDKK Q3 2021 Q3 2020 Q1-Q3 2021 Q1-Q3 2020 2020 Net sales

Nomination Committee RugVista Group AB (publ) appointed

The Nomination Committee of RugVista Group AB (publ) (“RugVista”) has been formed in accordance with the company’s “Instruction for appointing the Nomination Committee” as adopted by the Annual General Meeting. The Nomination Committee appointed for RugVista’s 2022 Annual General Meeting has the following composition: · Andreas Nyberg (representative of Litorina IV L.P) · Klara Tersman (representative of TIN Fonder) · Erik Lindgren (chairperson of the RugVista Board and the Nomination Committee) Shareholders who wish to submit proposals to the Nomination Committee are welcome

Talkpool Interim Report, January - September 2021

[][][][] Jul 1[st] – Sep 30[th], 2021 Jan 1[st] – Sep 30[th], 2021 · Net sales amounted to EUR 5 831 · Net sales amounted to EUR 17 768thousand (5 112), a 14.1 percent thousand (14 883), a 19.4 percentincrease increase · EBITDA of EUR 352 thousand (282) · EBITDA of EUR 783 thousand (486)and EBITDA margin of 6.0 percent (5.5) and EBITDA margin of 4.4 percent (3.3) · EBIT of EUR 285 thousand (172) · EBIT of EUR 523 thousand (183)and EBIT margin of 4.9 percent (3.4) and EBIT margin of 2.9 percent (1.

KEBNI RELEASES QUARTERLY REPORT FOR Q3 2021, JULY - SEPTEMBER

KebNi tightens the arc.During the third quarter of the year, KebNi took its starting point in the future. In parallel with deliveries to our customer in Israel and thus a stabilized cash flow, as well as further focus on sales work with more customer visits and quotation deliveries, intensive strategy work has been done during the quarter. Within that work, we have seen great opportunities and have paved the way to reach them. KebNi plans to grow both organically and through acquisitions. The organic part of the business plan states that KebNi aims to:• Grow SATCOM faster than the

Formica Capital invests 115 MSEK in ChargeNode

ChargeNode, a green tech company that eliminates the need for traditional EV chargers, has raised 115 MSEK from Formica Capital to accelerate Swedish and international expansion. ChargeNode fits very well into Formica’s focus on fast-growing companies with climate-effective solutions for properties, being Formica’s fifth investment in this segment. ChargeNode’s patent-pending technology for EV charging consists of a central charging unit that enables charging of more than 50 electric vehicles. Its innovative charging technology reduces power requirement and operational cost while

KONE completes repurchase of own shares

KONE Corporation, stock exchange release, November 18, 2021 at 9.20 a.m. EET KONE completes repurchase of own shares KONE has completed the repurchase of the company’s own class B shares, which started on November 11, 2021 and ended on November 17, 2021. During this period, a total of 750,000 own shares were repurchased for an average price of EUR 60.9629 per share. The shares were repurchased in public trading on Nasdaq Helsinki Ltd. at the market price prevailing at the time of purchase. The shares were repurchased on the basis of the authorization given by the Annual General

BioStock: PolarCool enters English Premier League market

PolarCool’s brain cooling device for treating concussions, PolarCap System, continues to make to breakthroughs in new markets. This week, the Swedish medtech company has announced signing an agreement with the English Premier League club Leeds United, thus entering what is arguably the most recognised sports league in the world.Read the article at biostock.se : https://www.biostock.se/en/2021/11/polarcool-enters-english-premier-league-market/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se 

Publication of Anora’s Interim Report for January-September 2021 on 25 November and invitation to results presentation

Anora Group Plc  Press release  18 November 2021 at 9:15 am EET Publication of Anora’s Interim Report for January-September 2021 on 25 November and invitation to results presentation Anora will publish its Interim Report for January–September 2021 on Thursday 25 November at around 8:30 am EET. CEO Pekka Tennilä and CFO Sigmund Toth will present the report on the same day at 11:00 am EET. The presentation will be held as a Microsoft Teams Meeting. We recommend that participants join the event using the online meeting option: Join meeting here 

There are no items matching the current filter
There are no more items matching the current filter
Back to top